Claritev Corporation (CTEV)

Market Cap	457.95M -52.7%
Revenue (ttm)	1.02B +6.9%
Net Income	-275.14M
EPS	-16.39
Shares Out	17.07M
PE Ratio	n/a
Forward PE	3.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175,322
Open	28.09
Previous Close	26.90
Day's Range	26.77 - 28.32
52-Week Range	11.50 - 55.50
Beta	1.05
Analysts	Buy
Price Target	48.60 (+81.21%)
Earnings Date	Nov 9, 2026

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical neg...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 3,000
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2025, Claritev's revenue was $965.41 million, an increase of 3.74% compared to the previous year's $930.62 million. Losses were -$284.28 million, -82.73% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for CTEV stock is "Buy." The 12-month stock price target is $48.6, which is an increase of 81.21% from the latest price.

Price Target

$48.6

(81.21% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 14, 2026

Data Sources Report a data error